 |
|
Spring Meeting 2009 Trial Reports |
| ID |
Study Title |
Status |
|
BR.10 |
A Phase III Prospective Randomized Study of Adjuvant Chemotherapy with Vinorelbine and Cisplatin in Completely Resected
Non-Small Cell Lung Cancer with Companion Tumour Marker Evaluation |
Closed |
|
BR.15 |
A Phase III Trial of Cisplatin/Etoposide/Radiotherapy with Consolidation Docetaxel Followed by Maintenance Therapy with
ZD1839 or Placebo in Patients with Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BR.15C |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer MORE... |
Closed |
|
BR.16 |
Phase III Chemoprevention Trial of Selenium Supplementation in Persons With Resected Stage 1 Non-Small Cell
Lung Cancer
MORE... |
Closed |
|
BR.17 |
Phase III Study of Tomudex and Cisplatin versus Cisplatin in Malignant Pleural Mesothelioma (EORTC: 08983)
MORE... |
Closed |
|
BR.18 |
A Phase II/III Double Blind Randomized Trial of BMS-275291 versus Placebo in Patients Receiving Paclitaxel/Carboplatin
Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BR.19 |
A Phase III Prospective Randomized Double Blind Placebo Controlled Trial of the Epidermal Growth Factor Receptor
Antagonist ZD1839 (IRESSA) in Completely Resected Stage IB, II, and IIIA Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BR.20 |
A Phase II Study of ZD6474 or Placebo in Small Cell Lung Cancer Patients Who Have Complete or Partial Response to
Induction Chemotherapy plus Radiation Therapy
MORE... |
Closed |
|
BR.21 |
A Randomized Placebo Controlled Study of OSI-774 (Tarceva) in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung
Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease
MORE... |
Closed |
|
BR.22 |
A Randomized Phase III Trial of Surgery Alone or Surgery plus Preoperative Paclitaxel/Carboplatin in Clinical Stage IB
(T2N0), II (T1-2N1, T3N0) and Selected IIIA (T3N1) Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BR.22C |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer (SWOG: 9925)
MORE... |
Closed |
|
BR.23 |
A Phase II Trial of Induction Chemoradiotherapy with Cisplatin/Etoposide Followed by Surgical Resection, Followed by
Docetaxel, for Non-Small Cell Lung Cancer Involving the Superior Sulcus (Pancoast Tumours)
MORE... |
Closed |
|
BR.23C |
This Protocol is a Laboratory Companion for Southwest Oncology Group Coordinated Trials for Lung Cancer
MORE... |
Closed |
|
BR.24 |
A Phase II/III Double Blind Randomized Trial of AZD2171 versus Placebo in Patients Receiving Paclitaxel/Carboplatin
Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BR.25 |
A Phase II Study of Hypofractionated 3-Dimensional Conformal Radiotherapy (3DCRT) for Inoperable Stage I/II Non-Small
Cell Lung Cancer (NSCLC)
MORE... |
Closed |
|
BR.26 |
A Double Blind Placebo Controlled Randomized Trial of PF-804 in Patients With Incurable Stage IIIB/IV
Non-small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease
MORE... |
Open |
|
BR.28 |
Concurrent ONce-daily VErsus twice-daily RadioTherapy: A 2-Arm Randomized Controlled Trial of Concurrent Chemo-Radiotherapy Comparing Twice-daily and Once-daily Radiotherapy Schedules in Patients with Limited Stage Small Cell Lung Cancer (SCLC) and Good Performance Status
MORE... |
Open |
|
BR.29 |
A Double Blind Randomized Trial of Cediranib versus Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy
for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer )
MORE... |
Open |
|
BRC.1 |
A Phase III Comparison of Prophylactic Cranial Irradiation versus Observation in Patients with Locally Advanced
Non-Small Cell Lung Cancer
MORE... |
Closed |
|
BRC.2 |
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab For Patients with Completely Resected
Stage IB (> 4 CM) - IIIA Non-Small Cell Lung Cancer (NSCLC)
MORE... |
Open |
|
BRC.2E |
A Prospective Economic Analysis of NCIC CTG BRC.2/E1505
A Phase III Randomized Trial of Adjuvant Chemotherapy with
or without Bevacizumab For Patients with Completely Resected Stage IB (> 4 CM) - IIIA Non-Small Cell
Lung Cancer (NSCLC)
MORE... |
Open |
|
BRC.3 |
A Randomized Phase III Trial of Cisplatin and Irinotecan (NSC-616348) versus Cisplatin and Etoposide in Patients
with Extensive Stage Small Cell Lung Cancer (E-SCLC)
MORE... |
Closed |
|
BRC.4 |
A Phase III Biomarker Validation Study of Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Randomized to Pemetrexed Versus Erlotinib
MORE... |
Closed |
|
BRC.5 |
A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (< 2cm) Peripheral Non-Small
Cell Lung Cancer
MORE... |
Open |
